This liquid formulation combines two synthetic research peptides that have been investigated in published scientific literature involving peptide chemistry, molecular biology, protein interactions, cellular communication, extracellular matrix research, and experimental laboratory models
Talk with the AgeRejuvenation team about a Peptide Therapy plan built around your labs and goals.
Our licensed medical team administers the injection quickly and comfortably in minutes
What the clinical trial evidence shows Mounjaro (tirzepatide) ~22.5% average body weight lost at 72 weeks ( SURMOUNT-1, 15mg) Wegovy (semaglutide) ~14.9% average body weight lost at 68 weeks ( STEP-1 , 2.4mg) Saxenda / Nevolat (liraglutide) ~5-8% average body weight lost at 56 weeks ( SCALE trial ) For context, prior to GLP-1 medications, the most effective non-surgical weight loss intervention available was a combination of intensive lifestyle modification and Orlistat , which typically produces 5 to 8% weight loss
This phase is about assessment, not results